Duygu Selcen
Department of Neurology
Mayo Clinic
Rochester
USA
Name/email consistency: high
- GFPT1-myasthenia: clinical, structural, and electrophysiologic heterogeneity. Selcen, D., Shen, X.M., Milone, M., Brengman, J., Ohno, K., Deymeer, F., Finkel, R., Rowin, J., Engel, A.G. Neurology (2013)
- Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy. Selcen, D., Bromberg, M.B., Chin, S.S., Engel, A.G. Neurology (2011)
- Myofibrillar myopathies. Selcen, D. Neuromuscul. Disord. (2011)
- Myofibrillar myopathies. Selcen, D. Curr. Opin. Neurol. (2010)
- Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Selcen, D., Muntoni, F., Burton, B.K., Pegoraro, E., Sewry, C., Bite, A.V., Engel, A.G. Ann. Neurol. (2009)
- Myofibrillar myopathies. Selcen, D. Curr. Opin. Neurol. (2008)
- The Z-disk diseases. Selcen, D., Carpén, O. Adv. Exp. Med. Biol. (2008)
- Mutations in ZASP define a novel form of muscular dystrophy in humans. Selcen, D., Engel, A.G. Ann. Neurol. (2005)
- Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients. Selcen, D., Ohno, K., Engel, A.G. Brain (2004)
- Mutations in myotilin cause myofibrillar myopathy. Selcen, D., Engel, A.G. Neurology (2004)
- Are MuSK antibodies the primary cause of myasthenic symptoms?. Selcen, D., Fukuda, T., Shen, X.M., Engel, A.G. Neurology (2004)
- Myofibrillar myopathy caused by novel dominant negative alpha B-crystallin mutations. Selcen, D., Engel, A.G. Ann. Neurol. (2003)
- Otocerebral anomalies associated with topical tretinoin use. Selcen, D., Seidman, S., Nigro, M.A. Brain Dev. (2000)